- E-postanne.stavelin@uib.no
- BesøksadresseAlrek helseklynge, blokk D, Årstadveien 175009 Bergen
- PostadressePostboks 78045020 Bergen
Vitenskapelig artikkel
- (2023). Aggregated data from the same laboratories participating in two glucose external quality assessment schemes show that commutability and transfers of values to control materials are decisive for the biases found. Clinical Chemistry and Laboratory Medicine.
- (2022). Using three external quality assurance schemes to achieve equivalent international normalized ratio results in primary and secondary healthcare. Clinical Chemistry and Laboratory Medicine. 419-426.
- (2022). Point-of-care testing in primary healthcare: a scoring system to determine the frequency of performing internal quality control. Clinical Chemistry and Laboratory Medicine. 740-747.
- (2022). A national surveillance program for evaluating new reagent lots in medical laboratories. Clinical Chemistry and Laboratory Medicine. 351-360.
- (2021). Feasibility for aggregation of commutable external quality assessment results to evaluate metrological traceability and agreement among results. Clinical Chemistry and Laboratory Medicine. 117-125.
- (2020). Performance of Afinion HbA1c measurements in general practice as judged by external quality assurance data. Clinical Chemistry and Laboratory Medicine. 588-596.
- (2020). Harmonising EQA schemes the next frontier: Challenging the status quo. Clinical Chemistry and Laboratory Medicine. 1795-1797.
- (2019). Pre-analytical practices for routine coagulation tests in European laboratories. A collaborative study from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM). Clinical Chemistry and Laboratory Medicine. 1511-1521.
- (2019). Commutability of a whole-blood external quality assessment material for point-of-care C-reactive protein, glucose, and hemoglobin testing. Clinical Chemistry. 791-797.
- (2018). Harmonization activities of Noklus - A quality improvement organization for point-of-care laboratory examinations. Clinical Chemistry and Laboratory Medicine. 106-114.
- (2017). Analytical performance specifications for external quality assessment - Definitions and descriptions. Clinical Chemistry and Laboratory Medicine. 949-955.
- (2016). The importance of reagent lot registration in external quality assurance/proficiency testing schemes. Clinical Chemistry. 708-715.
- (2016). Effect of participating in a quality improvement system over time for point-of-care c-reactive protein, glucose, and hemoglobin testing. Clinical Chemistry. 1474-1481.
- (2015). Egenkontroll av warfarinbehandling. Tidsskrift for Den norske legeforening. 849-853.
- (2014). The influence of coagulation factors on the in-treatment biological variation of international normalized ratio for patients on warfarin. Scandinavian Journal of Clinical and Laboratory Investigation. 470-476.
- (2013). External quality assessment of point-of-care methods: model for combined assessment of method bias and single-participant performance by the use of native patient samples and noncommutable control materials. Clinical Chemistry. 363-371.
- (2012). The Accu-Chek Mobile blood glucose monitoring system used under controlled conditions meets ISO 15197 standards in the hands of diabetes patients. Scandinavian Journal of Clinical and Laboratory Investigation. 374-379.
- (2012). External quality assessment of point-of-care International Normalized Ratio (INR) testing in Europe. Clinical Chemistry and Laboratory Medicine. 81-88.
- (2012). Effect of coagulation factors on discrepancies in International Normalized Ratio results between instruments. Clinical Chemistry and Laboratory Medicine. 1611-1620.
- (2010). Discrepancies in International Normalized Ratio Results between Instruments: A Model to Split the Variation into Subcomponents. Clinical Chemistry. 1618-1626.
- (2009). Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials. Thrombosis and Haemostasis. 593-600.
- (2006). External quality assessment of prothrombin time: The split-sample model compared with external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation. 337-349.
Leserinnlegg
- (2007). Response to Kitchen et al.'s external quality assessment of prothrombin time: The split-sample model compared to external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation. 676-677.
Short communication
- (2005). Analyse av protrombintid i primærhelsetjenesten. Tidsskrift for Den norske legeforening. 2048-2049.
Kronikk
- (2017). Bioingeniører må forske på eget fag :. Bioingeniøren. 22-23.
Brev til redaktøren
- (2017). Effect of dabigatran treatment at therapeutic levels on point-of-care international normalized ratio (INR). Clinical Chemistry and Laboratory Medicine. e143-e145.
Doktorgradsavhandling
- (2013). Analytical quality control of INR measurements in primary care.
Sammendrag/abstract
- (2013). Pre-analytical routines in coagulation testing: are guidelines followed? Journal of Thrombosis and Haemostasis. 18-18.
- (2005). External quality assessments of whole blood prothrombin time: Comparison of two methods. Clinica Chimica Acta.
Vitenskapelig oversiktsartikkel/review
- (2023). Analytical performance specifications and quality assurance of point-of-care testing in primary healthcare. Critical reviews in clinical laboratory sciences.
- (2017). Essential aspects of external quality assurance for point-of-care testing. Biochemia Medica. 81-85.
- (2017). An overview of the European organization for external quality assurance providers in laboratory medicine (EQALM). Biochemia Medica. 30-36.